Hopes rise for development of universal flu vaccine
Tuesday 31 January 2012
Newly discovered flu molecules shared by most strains of the virus
could help scientists develop a "universal vaccine", it was claimed
Researchers identified the molecules after after subjecting healthy volunteers to flu infections.
They found that participants' immune systems targeted a specific range of peptides, or protein building blocks, within the internal structure of the flu virus.
Harnessing the immune system's response to the peptides could produce an all-encompassing multi-strain vaccine, the scientists believe.
Current flu vaccines produce an antibody response to surface molecules which alter rapidly to keep one step ahead of the immune system.
But the internal peptides only change very slowly and do not vary between strains. They also trigger a response from T-cells - white blood cell elements of the immune system - rather than antibodies.
A T-cell vaccine aimed at the molecules has the potential to provide long-term immunity against all major flu strains, including seasonal, avian (bird) and swine viruses.
Past flu pandemics have caused disaster on a global scale. The 1918 Spanish Flu pandemic killed up to 40 million people, more than the number who died in the First World War.
Britain's last pandemic outbreak of swine flu in 2009 claimed 457 lives. Experts believe more severe pandemics may occur in the future, possibly as a result of a mutated avian (bird) flu strain.
Study leader Dr Tom Wilkinson, from the University of Southampton, said: "Influenza is a virus that we know has a global impact, and the threat of further pandemics is a real one.
"Most influenza vaccines only protect us against known influenza strains by creating antibodies in the blood but the influenza virus has the ability to rapidly change itself and new strains can emerge which rapidly spread across the globe by escaping this immunity.
"We have found that there is an important role for T-cells that recognise the flu virus, which if harnessed could protect against most or even all strains of seasonal and pandemic flu.
"Through this discovery we hope to improve vaccines for future strains of influenza, and potentially protect against the next pandemic. However there is more to do to translate these findings into new approaches to treatment."
The research is published in the latest on-line edition of the journal Nature Medicine.
Co-author Professor Sir Andrew McMichael, director of the Medical Research Council Weatherall Institute of Molecular Medicine at Oxford University, said: "Current flu vaccines are very good at producing antibodies against flu, but not so good at generating a lasting immunity involving T-cells.
"The big question is: if we had a pandemic involving a much more severe virus than the swine flu we saw, what would we do in the six months it takes to develop an effective vaccine? This study suggests that vaccines stimulating a T-cell response might be an option, but there remains a lot to do to be certain of this approach."
Life & Style blogs
Titanfall lands with a boom on Xbox One, but will it save Microsoft's console?
Tomnod: How to join the virtual search party scanning satellite imagery for missing flight MH370
'100 retweets and I'll shoot someone': American man arrested for Twitter threat
Gauthier Soho has ranted against 'food blaggers' - so can we really trust online reviews?
Whaling: Vine's latest trend sees users bending over backwards to get noticed
- 1 Is your name now 'banned' in Saudi Arabia?
- 2 Tony Benn meets Ali G: Watch Labour veteran burn Sacha Baron Cohen
- 3 Women do experience two different types of orgasm, study reveals
- 4 Istanbul protesters take 'Ellen selfie' from the back of a police van
- 5 Lady Gaga has struggled with eating disorders in the past, so it's indefensible that she's glamourising bulimia in her SXSW set
£50000 - £60000 per annum: Charter Selection: This well respected and exciting...
£40000 - £50000 per annum: Charter Selection: This exciting company and market...
£40000 - £60000 per annum + EXCELLENT SALARY: Austen Lloyd: Senior Private Cli...
£25,000 to £35,000: IT Connections Ltd: Signal Processing Engineer / Acoustics...